Skip to content

Falcon's Beyond Global FBYD Exchange Offer (Note 12)

Exchange Offer (Note 12) at other companies

Centerspace logo
CenterspaceCSR
$43K-93.9%
Empire State Realty Trust logo
Empire State Realty TrustESRT
$5.99M+278%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$28.57M
Macerich logo
MacerichMAC
$5.23M+4,335%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$52.83M
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$126.92M

Other financials

Income statement

See full
Revenue$5.4M+215%
Operating income$6.5M+202%
Net income$3.1M+185%
EPS (diluted)$0.05+138%

Balance sheet

See full
Cash & equivalents$1.2M+6.1%
Total debt$10.5M-73.2%
Total equity$14.9M+229%
Total assets$62.4M+9.9%

Cash flow

See full
Operating cash flow-$2.8M-391%
CapEx$12.0K-87.0%
Free cash flow-$2.8M-424%

Valuation

See full
Market cap$848.4M+309%
Enterprise value$857.7M+250%
P/E47.7×+43.0×
P/S45.7×+15.8×

Profitability

See full
Operating margin-3.1%-1.6pp
Net margin95.7%-534pp
FCF margin-152.8%+77.2pp

Returns & leverage

See full
Return on equity-36.2%
Debt / equity0.7×
Current ratio0.4×+0.4×

Where this comes from

Reported directly by Falcon's Beyond Global in its filing.

Tagged under the XBRL concept us-gaap:ConversionOfStockAmountConverted1.

The official record: Falcon's Beyond Global’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Falcon's Beyond Global's exchange offer (note 12).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Falcon's Beyond Global's exchange offer (note 12)?
Falcon's Beyond Global (FBYD) reported exchange offer (note 12) of $674K in Q4 2025.
How has Falcon's Beyond Global's exchange offer (note 12) changed year-over-year?
Falcon's Beyond Global's exchange offer (note 12) decreased by 87.8% year-over-year, from $5.54M to $674K.
What does exchange offer (note 12) mean?
Captures the value of stock exchanged or converted as part of a formal exchange offer or restructuring agreement. It provides insight into the company's efforts to simplify its capital structure or satisfy specific contractual obligations.